New EU Approvals
Executive Summary
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add three new products, including Astellas Pharma/FibroGen’s Evrenzo for treating adult patients with symptomatic anemia associated with chronic kidney disease.